Celltrion's IPO

Celltrion raised a round of funding on July 28, 2017. Investors include Public.

Celltrion (셀트리온) (KOSDAQ: 091990) is a biopharmaceutical company, specializing in research, development, and manufacture of biosimilar drugs. Celltrion strives to provide more affordable biosi…

Articles about Celltrion's IPO: